North East and North Cumbria
ICS Formulary
ICS Formulary
1 Gastro-intestinal system
01-06-06 Peripheral opioid-receptor antagonist
| Naldemedine Rizmoic® |
|
Formulary
|
200microgram tablet Approved for the treatment of opioid-induced constipation in line with NICE
|
 NICE TA651 - Naldemedine for treating opioid-induced constipation |
|
when used off-label peri-operatively to facilitate bowel recovery| Naloxegol |
|
Formulary
|
12.5mg and 25mg tablets Approved for the treatment of opioid-induced constipation in line with NICE
|
|
NICE TA345: Naloxegol for treating opioid‑induced constipation |
|
|
Links
- Guidelines for the Management of Adults with Asymptomatic Liver Blood Test Abnormalities
- NICE CG61: Irritable Bowel Syndrome
- NICE CG99: Constipation in children and young people
- NICE TA345: Naloxegol for treating opioid‑induced constipation
- NICE TA651 - Naldemedine for treating opioid-induced constipation
- North of Tyne, Gateshead and North Cumbria - Constipation Prescribing Guidelines
- North of Tyne, Gateshead and North Cumbria - Guidelines for Prescribing Trans Anal Irrigation as a Treatment for Chronic Constipation and Faecal Incontinence in Adults
- NTAG: Transanal irrigation (TAI) systems (Peristeen Plus®, Aquaflush®, and QuFora®) for neurogenic bowel dysfunction, chronic constipation and chronic faecal incontinence